US-COHORT ANALYSIS: FIVE-YEAR OUTCOMES OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS AND LUNG CANCER PRESCRIBED ANTIFIBROTICSGlenn Eiger, Jose Manuel Martinez Manzano, RAUL LEGUIZAMON et al.|CHEST Journal|2025Cited by 0
DOES A SINGLE HIGH BLOOD MONOCYTE COUNT IN PATIENTS WITH CORONARY ARTERY DISEASE CONFER A HIGHER RISK FOR INTERSTITIAL LUNG DISEASE AND PULMONARY FIBROSIS?Zurab Azmaiparashvili, IRAKLI LEMONJAVA, Phuuwadith Wattanachayakul et al.|CHEST Journal|2025Cited by 0
ASSOCIATION OF RECURRENT PNEUMONIA EVENTS WITH INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITISZurab Azmaiparashvili, Jose Manuel Martinez Manzano, RAUL LEGUIZAMON et al.|CHEST Journal|2025Cited by 0